22 unknown, 21 recruiting, 11 not yet recruiting, 10 completed. 27 Not applicable, 11 Phase 2, 5 Phase 3, 3 Phase 4, 2 Early Phase 1.
Follow Shanxi Bethune Hospital: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks No intervention; observational assessment only - Obesity & Overweight, Diabetes Mellitus, Type 2 | Not yet recruiting | Shanxi Bethune Hospital | 25974 | 2026-11-01 | 2026-10-21 | |
| Surgery vs. No Surgery for Primary Tumor in De Novo Stage IV Breast Cancer With Solitary Bone Metastases Primary Tumor Resection, Standard systemic therapy - Breast Cancer, Stage IV Breast Cancer | Not applicable | Not yet recruiting | West China Hospital | 216 | 2026-09-01 | 2026-07-07 |
| FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer Standard First-Line Therapy, FMT Combined with Standard First-Line Therapy - Unresectable Colorectal Cancer, Colorectal Cancer (Locally Advanced or Metastatic) | Phase 2 / Phase 3 | Not yet recruiting | Shanghai 10th People's Hospital | 220 | 2026-04-01 | 2026-04-03 |
| PregnAncy-Related Aortic DISsEction in China Intervention strategies including medication or surgery - Pregnancy Complication, Aortic Dissection | Recruiting | DeltaHealth Hospital ยท Shanghai | 500 | 2026-03-17 | 2026-07-17 | |
| CD30 CAR-T in the Treatment of CD30 Positive Lymphoma chimeric antigen receptor gene modified T cells - Lymphoma, B Cell Lymphoma | Early Phase 1 | Suspended | Shandong Qilu Cell Therapy Engineering Technology Co., Ltd | 15 | 2026-03-01 | 2026-09-28 |
| Clinical Study of Recombinant Anti-CD19m-CD3 Antibody Injection (A-319) Treatment with A319 - Acute Lymphocytic Leukemia | Not applicable | Not yet recruiting | Shanxi Bethune Hospital | 18 | 2026-02-02 | 2026-01-28 |
| Predicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study Selinexor-Based Regimen - Multiple Myeloma of Bone | Recruiting | Shanxi Bethune Hospital | 127 | 2026-01-01 | 2026-04-07 | |
| A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients NEPA, Dexamethasone, Megestrol Acetate - Breast Cancer Patients Treated With T-DXd | Phase 4 | Not yet recruiting | Tianjin Medical University Cancer Institute and Hospital | 120 | 2025-12-15 | 2025-11-28 |
| A Prediction Model in Pregnant Women With Aplastic Anemia A combined retrospective and prospective observational follow-up - Aplastic Anemia, Pregnancy | Recruiting | Peking University People's Hospital | 300 | 2025-11-27 | 2025-12-01 | |
| Intraosseous Infusion in Hematologic Critical Patients intra-osseous (IO) infusion needle/catheter - Intraosseous Infusions | Recruiting | Shanxi Bethune Hospital | 52 | 2025-11-22 | 2025-11-20 | |
| Somatostatin Plus Clear Liquid Diet Versus Diverting Stoma in Patients With Rectal Cancer Undergoing Ultra-Low Anterior Resection Somatostatin, Clear Liquid Diet, Prophylactic Diverting Stoma - Rectal Cancer, Anastomotic Leakage | Not applicable | Recruiting | Tongji Hospital | 72 | 2025-11-17 | 2026-05-26 |
| Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management Integrated TCM-Western Medicine Intelligent Diabetes Management Platform - Diabetes Mellitus, Type 2, Integrated Traditional Chinese Medicine and Western Medicine | Not applicable | Recruiting | Shanxi Bethune Hospital | 10000 | 2025-11-01 | 2025-12-04 |
| Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma Relapsed/Refractory Multiple Myeloma (RRMM), Multiple Myeloma | Recruiting | Shanxi Bethune Hospital | 48 | 2025-11-01 | 2026-03-27 | |
| Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients. Carbapenems, Anti-Gram-positive agent, Antifungal agent - Febrile Neutropenia | Recruiting | Shanxi Bethune Hospital | 20 | 2025-09-22 | 2025-10-02 | |
| CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma chimeric antigen receptor gene modified T cells - Lymphoma, B-Cell | Not applicable | Recruiting | Shanxi Bethune Hospital | 15 | 2025-09-05 | 2025-02-27 |
| A Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney Disease Six-channel RF Renal Denervation System, Parallel controln with sham operation(there is no rade and/or generic name,It is a blank control sham operation) - Hypertension, CKD - Chronic Kidney Disease | Not applicable | Enrolling by invitation | Shanghai Golden Leaf MedTec Co. Ltd | 236 | 2025-08-08 | 2026-02-11 |
| Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study Integrated IAV/MA Chemotherapy and Allo-HSCT Protocol for Adult AML, First Induction (IAV or DAV Regimen), Consolidation Therapy Options: MA or Intermediate-Dose Cytarabine Regimen - Acute Myeloid Leukemia | Phase 2 | Recruiting | Shanxi Bethune Hospital | 50 | 2025-08-06 | 2025-08-07 |
| Research on the Psychological Status of Patients With HIV-1 Infection All kinds of INSTI medications, All kinds of conventional medications - HIV-1-infection, Anxiety Depression | Not yet recruiting | Shanxi Bethune Hospital | 500 | 2025-08-01 | 2025-07-23 | |
| The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction HUAXI hole 1 - Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Not applicable | Recruiting | Du Zhenggui | 337 | 2025-06-17 | 2025-07-02 |
| Clinical Study on Improving Exercise Capacity in Chronic Obstructive Pulmonary Disease Through Smart IoT-Remote Home Breathing Guidance Breathing guided exercise, Flat walking training - Chronic Obstructive Pulmonary Disease | Not applicable | Not yet recruiting | Henan University of Traditional Chinese Medicine | 548 | 2025-06-15 | 2025-05-09 |
Showing 20 of 67. Sign in to see all of them.
Multiple Myeloma (4) · Breast Neoplasms (3) · COVID-19 (3) · Leukemia, Myeloid, Acute (3) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (3) · Pulmonary Disease, Chronic Obstructive (3) · Anemia, Aplastic (2) · Diabetes Mellitus, Type 2 (2) · Hypertension (2) · Lung Neoplasms (2) · Lymphoma (2) · Lymphoma, B-Cell (2) · Purpura, Thrombocytopenic, Idiopathic (2) · Rectal Neoplasms (2) · Thrombocytopenia (2)
Dexamethasone (2) · Gene Fusion (2) · Adrenal Cortex Hormones (1) · Antifungal Agents (1) · Aztreonam (1) · Carbapenems (1) · Catheters (1) · Celecoxib (1) · Cyclophosphamide (1) · Cytarabine (1) · DAV regimen (1) · Danazol (1) · Daunorubicin (1) · Emtricitabine (1) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1)
China (60) · Colombia (1) · El Salvador (1)
Jia Wei, M.D (2) · Jian-Wen Zhang, MD (2) · Xiaomin Zhang (2) · Ailin Luo (1) · Anbin Huang, MD. (1) · Bo Yu, M.D. (1) · Dan Han, Master (1) · Dongbao Zhao, MD. (1) · Fen Li, MD. (1) · Guangfa Wang, MD. (1) · Guanmin Gao, MD. (1) · Hongbin Li, MD. (1) · Hongsheng Sun, MD. (1) · Hui Luo, MD. (1) · Jiangang Shi, Doctor (1)
PMID 19953723, PMID 22252861, PMID 25929547, PMID 26756765, PMID 27544232, PMID 27792044, PMID 28973220, PMID 29723512, PMID 30236233, PMID 30292760, PMID 30998509, PMID 31794513, PMID 31939844, PMID 32077450, PMID 32303884, PMID 32417976, PMID 32677707, PMID 33540057, PMID 33555690, PMID 34496821, PMID 34859868, PMID 34916051, PMID 36525620, PMID 40468421, PMID 40731293, PMID 41077810
UH3CA189883 (1)